Journal
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
Volume 87, Issue 3, Pages -Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/mmbr.00045-22
Keywords
lipopolysaccharide; Gram-negative bacteria; vaccine; antimicrobial resistance; endotoxin; O polysaccharide
Categories
Ask authors/readers for more resources
Infections caused by antimicrobial-resistant bacteria pose a growing threat to various medical procedures and conditions, such as surgeries, organ transplants, and cancer treatment. The development of new antimicrobials is limited, therefore, vaccines targeting antimicrobial-resistant Gram-negative bacteria may be a valuable alternative to reduce antimicrobial usage and prevent bacterial transmission.
Infections with antimicrobial-resistant (AMR) bacteria pose an increasing threat to the ability to perform surgical procedures, organ transplantation, and treat cancer among many other medical conditions. There are few new antimicrobials in the development pipeline. Vaccines against AMR Gram-negative bacteria may reduce the use of antimicrobials and prevent bacterial transmission. This review traces the origins of lipopolysaccharide (LPS)-based vaccines against Gram-negative bacteria, the role of O polysaccharides and LPS core regions as potential vaccine targets, the development of new vaccine technologies, and their application to vaccines in current development. Infections with antimicrobial-resistant (AMR) bacteria pose an increasing threat to the ability to perform surgical procedures, organ transplantation, and treat cancer among many other medical conditions. There are few new antimicrobials in the development pipeline.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available